According to the case management order dated June 14, on hernia mesh involving C.R. Bard Inc.’s polypropylene implants, the U.S. District Court of the Southern District of Ohio has established protocols governing the examination and division of pathology specimens submitted for bellwether trial pool cases. The protocol was intended to ensure that any specimens not previously tested are preserved in a manner that parties can have equal access to the materials.
More than 2,400 hernia mesh lawsuits continue to move forward in the U.S. District Court, Southern District of Ohio, where all federally-filed injury claims involving C.R. Bard Inc.’s polypropylene implants have been centralized for coordinated pretrial proceedings. The lawsuits involve all the plaintiffs who suffered from hernia recurrence and other debilitating complications due to the allegedly defective nature of the defendants’ polypropylene mesh implants.
The court will announce the final three bellwether trial selections in February. Currently, each claim is undergoing case-specific discovery in preparation for three early trials set to begin in May 2020.
